US Democrat legislators have speedily launched their own proposal forMedicare prescription drug coverage for seniors, hot on the heels of President George W Bush sending to Congress his Immediate Helping Hand initiative (Marketletter February 5). Critics have said that the President's plan would do too little for too few people and would take too long to implement, while Democrat Senator Paul Wellstone described it as "a great leap sideways."
The Democrat proposal has been put together by the Progressive Caucus, a group of more than 50 Members of Congress. Their plan would cover 80% of prescription drug costs for all seniors under Medicare, representing around 40 million people. Despite this greater coverage, the Caucus members say the cost of implementing it would be about the same as for the Bush plan, as its financing would include a number of cost-containment provisions such as bulk drug purchasing to obtain large discounts and allowing the re-importation of US-made drugs from overseas.
Legislation permitting re-imports was signed into law by President Bill Clinton last October but his Health and Human Services Secretary, Donna Shalala, refused to back its implementation because of the "serious flaws and loopholes" in the final law, a decision which was supported by Pres Clinton (Marketletter January 1 & 8). However, the Democrats' new plan would add safety provisions such as requiring drugmakers to supply Food and Drug Administration-approved labels for re-imported drugs.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze